ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

  1. Redelman-Sidi, G.
  2. Michielin, O.
  3. Cervera, C.
  4. Ribi, C.
  5. Aguado, J.M.
  6. Fernández-Ruiz, M.
  7. Manuel, O.
Revista:
Clinical Microbiology and Infection

ISSN: 1469-0691,  1198-743X

Año de publicación: 2018

Volumen: 24

Páginas: S95-S107

Tipo: Revisión

DOI: 10.1016/J.CMI.2018.01.030 GOOGLE SCHOLAR lock_openAcceso abierto editor
Fuente de los datos: Scopus